M
Mary Jo Lund
Researcher at Emory University
Publications - 32
Citations - 2446
Mary Jo Lund is an academic researcher from Emory University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 22, co-authored 32 publications receiving 2263 citations. Previous affiliations of Mary Jo Lund include Center for Excellence in Education.
Papers
More filters
Journal ArticleDOI
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA
Mary Jo Lund,Katrina F. Trivers,Peggy L. Porter,Ralph J. Coates,Brian Leyland-Jones,Otis W. Brawley,Elaine W. Flagg,Ruth O'Regan,Sheryl G. A. Gabram,J. William Eley +9 more
TL;DR: The high prevalence of TNTs among younger women and particularly younger AA women, along with unique protein expression patterns and poorer survival, suggests varying gene–environment etiologies with respect to age and race/ethnicity and a need for effective therapies.
Journal ArticleDOI
The epidemiology of triple-negative breast cancer, including race
Katrina F. Trivers,Mary Jo Lund,Peggy L. Porter,Jonathan M. Liff,Elaine W. Flagg,Elaine W. Flagg,Ralph J. Coates,J. William Eley +7 more
TL;DR: Distinct breast cancer subtypes have unique sociodemographic, anthropometric and reproductive characteristics and possibly different pathways for development.
Journal ArticleDOI
Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma
Karin Gwyn,Melissa L. Bondy,Deborah S. Cohen,Mary Jo Lund,Jonathan M. Liff,Elaine W. Flagg,Louise A. Brinton,J. William Eley,Ralph J. Coates +8 more
TL;DR: Differences with respect to delays in the interval between medical consultation and the diagnosis and treatment of breast carcinoma are greater for African American women than for white women are examined.
Journal ArticleDOI
Influence of Race, Insurance, Socioeconomic Status, and Hospital Type on Receipt of Guideline-Concordant Adjuvant Systemic Therapy for Locoregional Breast Cancers
Xiao-Cheng Wu,Mary Jo Lund,Gretchen Kimmick,Lisa C. Richardson,Susan A. Sabatino,Vivien W. Chen,Steven T. Fleming,Cyllene R. Morris,Bin Huang,Amy Trentham-Dietz,Joseph Lipscomb +10 more
TL;DR: Sociodemographic and hospital factors are associated with guideline-concordant use of systemic therapy for breast cancer and the identification of modifiable factors that lead to nonguideline treatment may reduce disparities in breast cancer survival.
Journal ArticleDOI
General and abdominal obesity and survival among young women with breast cancer
Page E. Abrahamson,Marilie D. Gammon,Mary Jo Lund,Elaine W. Flagg,Peggy L. Porter,June Stevens,Christine A. Swanson,Louise A. Brinton,J. William Eley,Ralph J. Coates +9 more
TL;DR: Evidence that breast cancer survival is reduced among younger women with general or abdominal obesity is provided, particularly for abdominal obesity, in a cohort of young women with breast cancer.